Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Axsome Therapeutics Stock Price (Quote) NASDAQ:AXSM
$31.65 ( 0.44% ) Friday, 20th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $24.13 | $44.53 | Friday, 20th May 2022 AXSM stock ended at $31.65. This is 0.44% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 11.24% from a day low at $29.90 to a day high of $33.26. |
| 90 days | $24.13 | $47.40 | |
| 52 weeks | $19.38 | $74.10 |
Historical Axsome Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-20 | $32.01 | $33.26 | $29.90 | $31.65 | 839 640 |
| 2022-05-19 | $30.92 | $32.38 | $30.85 | $31.51 | 441 811 |
| 2022-05-18 | $32.53 | $33.64 | $30.53 | $31.13 | 664 604 |
| 2022-05-17 | $31.00 | $33.72 | $30.79 | $33.58 | 970 140 |
| 2022-05-16 | $27.92 | $30.93 | $27.13 | $30.82 | 574 984 |
| 2022-05-13 | $25.92 | $28.83 | $25.92 | $27.90 | 710 893 |
| 2022-05-12 | $25.21 | $26.00 | $24.13 | $25.34 | 1 304 569 |
| 2022-05-11 | $29.00 | $29.20 | $25.59 | $25.79 | 952 448 |
| 2022-05-10 | $28.48 | $29.60 | $27.06 | $29.29 | 918 610 |
| 2022-05-09 | $29.04 | $29.47 | $26.57 | $26.82 | 1 057 341 |
| 2022-05-06 | $36.01 | $36.06 | $28.86 | $29.82 | 2 982 174 |
| 2022-05-05 | $37.98 | $38.80 | $35.70 | $36.74 | 646 804 |
| 2022-05-04 | $36.45 | $38.64 | $34.10 | $38.50 | 1 107 146 |
| 2022-05-03 | $34.41 | $37.09 | $33.83 | $35.84 | 916 147 |
| 2022-05-02 | $31.11 | $34.16 | $30.20 | $34.04 | 1 339 037 |
| 2022-04-29 | $31.93 | $33.55 | $31.49 | $31.75 | 740 339 |
| 2022-04-28 | $30.94 | $32.61 | $29.70 | $32.00 | 866 614 |
| 2022-04-27 | $30.00 | $31.61 | $30.00 | $30.50 | 791 716 |
| 2022-04-26 | $30.18 | $30.95 | $28.97 | $29.99 | 1 707 473 |
| 2022-04-25 | $30.40 | $31.75 | $28.88 | $30.50 | 4 464 032 |
| 2022-04-22 | $39.20 | $40.08 | $38.60 | $39.06 | 259 039 |
| 2022-04-21 | $43.82 | $44.53 | $39.49 | $39.60 | 1 247 500 |
| 2022-04-20 | $40.59 | $43.52 | $39.07 | $43.04 | 1 749 900 |
| 2022-04-19 | $40.26 | $41.61 | $38.05 | $40.92 | 10 981 100 |
| 2022-04-18 | $36.69 | $36.73 | $32.57 | $32.70 | 989 500 |
| 2022-04-14 | $37.87 | $37.87 | $36.13 | $36.86 | 554 644 |
| 2022-04-13 | $38.19 | $39.66 | $37.98 | $37.99 | 604 602 |
| 2022-04-12 | $40.61 | $41.49 | $37.83 | $38.42 | 554 449 |
| 2022-04-11 | $40.45 | $41.23 | $39.25 | $40.42 | 708 743 |
| 2022-04-08 | $44.10 | $44.45 | $40.42 | $40.69 | 801 100 |
| 2022-04-07 | $46.85 | $47.04 | $43.40 | $44.20 | 767 100 |
| 2022-04-06 | $46.11 | $47.20 | $44.71 | $46.72 | 691 200 |
| 2022-04-05 | $46.56 | $47.40 | $45.78 | $46.75 | 517 600 |
| 2022-04-04 | $44.29 | $46.47 | $43.37 | $46.38 | 808 700 |
| 2022-04-01 | $41.82 | $43.95 | $41.38 | $43.91 | 689 803 |
| 2022-03-31 | $40.11 | $41.94 | $40.02 | $41.39 | 884 806 |
| 2022-03-30 | $39.42 | $41.40 | $38.51 | $40.01 | 961 008 |
| 2022-03-29 | $36.06 | $40.91 | $35.75 | $39.31 | 1 672 900 |
| 2022-03-28 | $36.47 | $39.29 | $34.51 | $35.11 | 1 494 700 |
| 2022-03-25 | $36.04 | $36.22 | $34.52 | $35.36 | 376 000 |
| 2022-03-24 | $34.81 | $35.98 | $34.75 | $35.98 | 427 900 |
| 2022-03-23 | $34.13 | $36.16 | $34.00 | $34.57 | 418 800 |
| 2022-03-22 | $33.38 | $34.93 | $33.21 | $34.44 | 421 191 |
| 2022-03-21 | $34.39 | $34.94 | $32.61 | $33.30 | 425 392 |
| 2022-03-18 | $33.93 | $35.10 | $33.33 | $33.61 | 1 118 148 |
| 2022-03-17 | $31.55 | $34.25 | $30.87 | $34.18 | 617 600 |
| 2022-03-16 | $29.60 | $31.55 | $29.00 | $31.51 | 628 400 |
| 2022-03-15 | $28.96 | $29.27 | $27.33 | $29.13 | 541 300 |
| 2022-03-14 | $33.01 | $33.03 | $27.88 | $28.60 | 863 700 |
| 2022-03-11 | $32.12 | $33.61 | $31.81 | $32.79 | 442 500 |
Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, develops therapies for the management and treatment of central nervous system disorders. Its product candidates include AXS-02, which is in Phase III trial for the treatment of complex regional pain syndrome, knee osteoarthritis, and chronic low back pain; and AXS-05 that is in Phase III trial for the treatment of resistant depression and agitation in patients with Alzheimer's... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
